Literature DB >> 22052614

Childhood onset of left ventricular dysfunction in a female manifesting carrier of muscular dystrophy.

Hugo R Martinez1, Ricardo Pignatelli, John W Belmont, William J Craigen, John L Jefferies.   

Abstract

Duchenne muscular dystrophy and Becker muscular dystrophy are X-linked disorders that result from a mutation in the dystrophin gene that reduces the production or effectiveness of the protein dystrophin. These disorders are clinically characterized by progressive muscle degeneration. Manifesting female carriers are generally not identified as such until after puberty, when symptoms such as muscle weakness may arise. This clinical report describes a female manifesting carrier who started to show deterioration of left ventricular systolic function, but no marked skeletal muscle weakness, at the age of 10 years. The patient's cardiac function improved significantly after dual drug therapy with an ACE inhibitor (enalapril) and a beta-blocker (carvedilol). Our case adds to the existing evidence that left ventricular myocardial dysfunction may occur during childhood in female carriers of dystrophinopathies.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052614     DOI: 10.1002/ajmg.a.33784

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Muscular and cardiac manifestations in a Duchenne-carrier harboring a dystrophin deletion of exons 12-29.

Authors:  Josef Finsterer; Claudia Stöllberger; Birgit Freudenthaler; Desiree De Simoni; Romana Höftberger; Klaus Wagner
Journal:  Intractable Rare Dis Res       Date:  2018-05

2.  Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.

Authors:  Vincenzo Giglio; Paolo Emilio Puddu; Giovanni Camastra; Stefano Sbarbati; Sabino Walter Della Sala; Alessandra Ferlini; Francesca Gualandi; Enzo Ricci; Federico Sciarra; Gerardo Ansalone; Marco Di Gennaro
Journal:  J Cardiovasc Magn Reson       Date:  2014-07-09       Impact factor: 5.364

Review 3.  Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.

Authors:  Kenji Rowel Q Lim; Narin Sheri; Quynh Nguyen; Toshifumi Yokota
Journal:  Genes (Basel)       Date:  2020-07-08       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.